Author: Dr. Joel Rutstein Offered: Weekly

Subscribe to this: (Click the above links to open this Podcast in the listed podcast sites.)

Average Rating: 4.5  Based on 3 ratings Click Stars to Rate: Review this title

Arthritis Central Podcast by Dr. Joel Rutstein

Dr. Joel E. Rutstein is the creator of ArthritisCentral.com. Since 1999, he has been using the Internet to help arthritis sufferers all over the world take back control of their arthritis and osteoporosis. Dr. Rutstein is responsible for all of the website's original content, including the Arthritis.TV video library. He has produced multiple full-length educational and inspirational video programs, available at ArthritisMall.com.

About Podcasting:
For those of you new to podcasting, Click Here to read our "Introduction to Podcasting" Article.

Write a Review of Arthritis Central Podcast

Excellent, June 11, 2006
Reviewer: kwaic

A very Brilliant site. Wealth of Rheumatology and Medical Info. Good for the laymen and for fellow medical/health professionals in terms of con't med education.

Pls continue this execllent job, kudos +++

Ky

personalmedia, February 17, 2006
Reviewer: personalmedia from Indiana

Dr. Joel Rutstein hosts a postcast that focuses on medical issues, specifically arthritis related disorders. Rutstein brings medical research to listeners in an easy to understand and interesting format. Though the program is targeted at arthritis sufferers, the medical topics the doctor covers are useful to all health-care consumers.

Dr. Rutstein also uses the platform of the podcast to share his personal views on controversial issues, but he does a good job of presenting both sides of the argument. Rutstein speaks clearly and is an advocate for consumers in this podcast that brings to light important topics on medical-related developments. Anyone who is dealing with the maze of healthcare and pharmaceuticals will find this program worth a preview.

Podcast Feed URL:

(Copy the above URL into your Podcast Application. Click Here to learn more.)

ArthritisCentral News and Views #45: Personal Story -- 05/19/06

feedback@arthritiscentral.com (Joel Rutstein M.D.) Author: Joel Rutstein M.D.
Fri, May 19, 2006

In fond memory of one of my sweetest patients with fibromyalgia who recently passed away from a massive stroke. Listen to her explanation of how she coped with her rheumatic condition over the years.

Download File - 6.1 MB
Listen To This Podcast (Streaming Audio)

• A report from the Women's Health Initiative has evaluated whether supplemental calcium and vitamin D provide any significant benefit in osteoporosis treatment.
  
• The study investigated whether the supplements provided any significant protection against future bone fractures.
  
• The study has a number of design flaws, which are pointed out. These include the fact that the control group was allowed to take calcium and vitamin D on their own along with hormonal therapy, bisphosphonates, and miacalcin.
  
• Scientists question whether the vitamin D dose of 400 I.U.s per day used in this study is really sufficient for women.
  
• Compliance in taking the calcium carbonate and vitamin D prescribed in this study was associated with a decreased rate of hip fracture, but unfortunately in those patients who failed to comply the benefits were not seen.
  
• The study re-emphasizes the need to be evaluated with bone mineral density measurements (DEXA scan) to see if you are truly osteoporotic. Taking calcium and vitamin D does not substitute for a proper evaluation by your physician for the presence of osteoporosis.
  
• Calcium and vitamin D are considered important background medications, but osteoporosis needs to be treated with more specific and stronger therapies including bisphosphonates (Fosamax, Actonel, Boniva), Forteo, Miacalcin nasal spray, or Evista.
  

• What is the current thinking on the role of estrogens in the development and prevention of osteoporosis?
  
• What about the use of the selective estrogen receptor modulator (SERM) called Evista? How does it work? Is it beneficial in fracture prevention? Can it be combined with other treatments? Are there any special side effects that should concern the patient?
  
• Is there a place for the use of the intra-nasal spray called Miacalcin in the treatment of osteoporosis? What are side effects of using this medication?
  
• What is Forteo and how does it work? Which patients are particularly good candidates to receive this treatment?
  
• Why is Forteo limited to two years of treatment only?
  
• What is Dr. Marwah's overall assessment of the current status of the diagnosis and treatment of osteoporosis in the United States?

Dr. Rutstein interviews Dr. Raj Marwah, a rheumatologist and Clinical Professor at the Department of Internal Medicine at Texas Tech Health Sciences in El Paso. Topics include:

• What are bisphosphonates and how do they work?
  
• Are there advantages of one bisphosphonate over another?
  (Fosamax vs. Actonel vs. Boniva)
  
• What special instructions should the patient follow in taking these medications to ensure maximum absorption of the drug with the fewest side effects?
  
• What adverse side effects are seen with use of bisphosphonates?

• How is osteoporosis actually diagnosed?
  
• What are bone turnover markers and how can they help physicians in monitoring patients with osteoporosis?
  
• What are the proper amounts of calcium to consume? Are there advantages of dietary versus supplemental calcium?
  
• How important is it to have adequate vitamin D levels and how can a vitamin D deficiency be diagnosed?
  
• How should patients be monitored while being followed and treated for osteoporosis?
  
• What information did we learn from the Surgeon General's report on bone health?

• What exactly is osteoporosis?


• How does it differ from osteopenia?


• What are some of the important risk factors involved in developing this
  condition?


• What is the likely future course of a patient who develops an initial fracture
  due to osteoporosis?


• Plus more!
  

• Are glucosamine and chondroitin sulfate supplements really of any value? The results of the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) were reported at the American College of Rheumatology meeting in San Diego. Tune in to hear these long awaited results.
  
• At Arthritis Central we have been touting the benefits of a good exercise program including walking. Can walking on a regular and frequent basis add years to your lifespan? Check out a report by Dutch investigators to find out the answer.
  
• Researchers are discovery key pathways involved in the development of osteoarthritis in rodents that may eventually have implications in the treatment of human beings.
  
• Milk advertising strategies are changing as a result of so many food and beverage companies making claims regarding their calcium benefits. You may be amused by this new approach.
  
• On a personal note, Dr. Rutstein is pleased to tell you about his mother's recovery from a lumbar fusion. This was a "tough haul" for an 83 year old woman. Dr Rutstein so pleased that she made it through without any unforeseen complications. If you can take better care of yourself and stay out of hospitals, you are far better off!

• Are you having problems with rudeness from the front office staff in your doctor's office? If you are, apparently you are not alone. Hear more about this problem and how you can actually help cut down on the likelihood of experiencing this on future visits.
  
• Are you taking Zanaflex (tizanidine hydrochloride) for muscle pains or spasms? You will want to listen to this alert about the Zanaflex capsules versus a tablet form of tizanidine.
  
• If you are giving your child supplements without your pediatrician's knowledge, then you may be putting them at risk of potential side effects. Dr. Rutstein reviews some of the problems that have been encountered with some of these over-the-counter products.
  
• Where do these free samples of medications in your doctor's office come from? HMOs are now participating in a program to put ATM like generic medication dispensing machines in your physician's office. Learn more about why they are going to this effort and expense.

• Should you sign up for the Medicare prescription drug plan? Which one is best for you? Listen for answers to these and other questions. Visit www.medicarerxeducation.org for more information. More information can also be found in Podcast #25.
  
• Scientists have uncovered an "inflammation" gene that may be an important key to various chronic diseases including arthritis, heart disease, diabetes, cancer, and Alzheimer's disease.
  
• Do placebos really work? How can a sugar pill or salt water be so helpful in relieving pain? A new study sheds light on this process.
  
• You may be able to save money on your Arava (leflunomide) with this latest FDA approval of generic tablets.
  
• Endomorphin I is a natural pain reliever found in the joint itself. Is there any evidence that it might be helpful in a chronic problem like osteoarthritis? Hear the results from this most recent study.
  
• OxyContin has been fraught with problems because of its abuse. A new drug called Remoxy may be on the way, which will avoid the OxyContin abuse potential. If you have severe chronic pain then you will want to hear the latest news about Remoxy. This may be something that eventually could help to control your pain once it is available on the market.

• Depression in individuals over 65 is a significant health issue. A Wall Street Journal written by Laura Landro is reviewed shedding light on this subject.
  
• For more information on this subject, visit www.nimh.nih.gov, wwww.depressionscreening.org, www.positiveaging.org, and www.aagpgpa.org.
  
• Are you having difficulty falling asleep at night? A new drug now out on the market may be 'just the ticket".
  
• Some patients with scleroderma (systemic sclerosis) may develop lung (pulmonary) involvement. Researchers compared cyclophosphamide (Cytoxan) with a placebo to determine if this drug offers any improvement in lung function and in skin tightness scores. The results of the study and issues about side effects are discussed.
  
• Are there any indications that osteoarthritis actually starts long before it becomes symptomatic to the patient or obvious to your physician?
  
• Abbott's Humira drug has received new FDA approval as a first-line treatment in rheumatoid arthritis.
  
• Does Lympho-Stat-B hold any promise for systemic lupus patients? Hear about the results of the most recent study.
  
• A new synthetic version of a cell surface protein called PLAD (pre-ligand assembly domain protein) may offer patients an alternative approach to the treatment of inflammatory forms of arthritis. Will this turn out to be safer than the currently used anti-TNF therapies (Enbrel, Remicade, Humira)?
  
• Who should be taking a new formulation of Fosamax that incorporates 2800 units of vitamin D3? How many women in North America have been found to be vitamin D deficient? If you are already taking vitamin D daily, must you switch to this new Fosamax tablet? Make sure that you find out from your doctor whether you have osteoporosis or osteopenia and whether or not you need to be on therapy.

• A Wall Street Journal article written by Kelly Greene stimulates a discussion of how Baby Boomers will be re-shaping life in the next two or more decades.
  
• Should you pay for assisted living down the road or just go on a year long cruise? Are the costs that different?
  
• What are "brain gyms" and "cognitive fitness centers" ? Are there really ways to improve your memory?
  
• Listen to the news about how some people are just "dying" to tell you their life stories.
  
• Learn about research into a new form of methotrexate combined with a protein called albumin. This may increase the amount of methotrexate getting into your cells and into the joints.
  
• We alert you about a recent report of increased cardio-vascular risk with the combination of vitamin B-6 and folic acid. How disconcerting and confusing these reports can be!
  
• Should you be considering ordering your medications through a Canadian Internet pharmacy? Is it even legal to do so? Are brand-name medications cheaper when purchased in Canada than in our large drug store chains?
  
• Why haven't electronic medical records (EHR) been accepted and instituted by more doctors' offices and in our hospitals? What's gumming up the works? When will all of your doctors be able to easily access the same information about your health?
  

• Are people who have a lot of contact with mineral oils more at risk to develop rheumatoid arthritis? A study from Sweden addresses this issue. Does this apply to men and women? What is the relationship to rheumatoid factor antibodies?
  
  
• Learn the fate of Pfizer's drug application for Paracoxib for the treatment of post-operative pain. Paracoxib is an intra-venous "pro-drug" of Bextra, which was itself previously taken off of the market by the FDA.
  
  
• Aromatase inhibitors have been an extremely welcome addition for breast cancer patients. Now we report on a recently reported side effect of this family of medications and tell you what you can do about it.
  
  
• The mystery of psoriasis and the differences behind the cutaneous form and arthritic manifestations are discussed in this piece involving a new mouse model of this disease. This information will help explain why TNF inhibitors like Enbrel, Remicade, and Humira are helpful in treating this disease.
  
  
• Eating a portion of fish at least once a week may help stave off mental deterioration in later life (dementia). It's not some "fish tale" to say that adding fish to your diet may add years to your life.
  
  
• Obesity, hypertension, and elevated cholesterol levels may each double your risk of becoming demented. Having all three together in middle age jumps the risk factor up even more. It's time to take action to combat these treatable problems.
  
  
• A report from Duke University gives us better parameters on just how much brisk walking a person needs to do in order to be fit and decrease one's cardio-vascular risk. You will be surprised to hear whether it's necessary to lose weight or not in order to achieve these benefits.
  

• In this program the subject of the under treatment of pain is discussed. Physicians have a number of fears about prescribing narcotics, which are addressed. Patients worry about potential addiction and the possibility of side effects. A piece written by Barry Yeoman in AARP, The Magazine is reviewed.
  
• Physician and patient concerns are contributing to under treating pain in one half of all cancer patients, even in the final days of patients' lives. This is totally unacceptable.
  
• A very exciting breakthrough in stem cell research has been reported by investigators in Boston. This technique involves using one's own skin. This may pacify many opponents of stem cell research, who have been concerned about using stem cells derived from human embryos.
  
• Can varying your activities and stimulating your various senses result in an increase in the connections among brain cells or even an increase in the number of nerve cells? The subject of "neural reserve" and how to improve it is discussed. A series of helpful techniques to keep you sharper and more alert is presented. An AARP article written by Kelly Griffin is critically reviewed dealing with this important area. For those of you interested in learning to spell words using your hands, visit www.iidc.indiana.edu/cedir/kidsweb/amachart.html.
  
• A New York Times article written by Gina Kolata challenges the rapidly increasing usage of vertebroplasty or kyphoplasty to treat compression fractures in the spine. Is it possible to get patients to enroll in a placebo-controlled study when the response to an injection of cement into the vertebral body may be so dramatic in promptly reducing severe back pain?
  
• Kevin Trudeau's best seller "Natural Cures They Don't Want You to Know About" may be a "hot" book, but does it contain scientific and valid information? Dr. Rutstein cites quotes by Dr. Dean Ornish and others from a recent New York Times article by Melanie Warner that suggests that the author and his material may not be all that they appear. Kevin Trudeau's "dark" past life certainly casts a shadow over this best-selling book. Dr. Rutstein cautions those of you who are feeling frustrated and desperate not to throw your money down the toilet with unproven remedies. Keep abreast of alternative therapies that have some validity and certainly discuss your feelings with your own physician.
  

• Each of the TNF blockers is specifically addressed in this program (Enbrel, Remicade, and Humira).
  
• Injection site reactions from Enbrel are addressed.
  
• Concerns about potential infections associated with TNF inhibitors are discussed. This includes comments about the assessment and treatment of tuberculosis in the face of biologic agents.
  
• Can TNF inhibitors affect your red cell, white cell, and platelet (clotting cells) counts? Is there a higher risk of cancer with these drugs? Dr. Zashin and Dr. Rutstein touch on these subjects.
  
• Is there an increased likelihood of problems if TNF blockers are administered to multiple sclerosis patients?
  
• Should TNF inhibitors be utilized in patients with a confirmed diagnosis of congestive heart failure?
  
• The issue of the high cost of biologic therapies is discussed with differences in insurance coverage among the three existing drugs pointed out.
  
• What are "infusion reactions" which may occur with Remicade, and how are they managed?
  
• Do some patients receiving TNF inhibitors form lupus symptoms or lupus antibodies?
  
• What should patients on TNF drugs know about flu and pneumovax vaccinations? Are "live" flu vaccines dangerous in this setting?
  
• How hard is it to overcome a patient's fears of having to self-inject medication under the skin?
  
• If you fail to respond to one particular TNF inhibitor, is it possible to respond to one of the other two TNF blockers?
  
• How long should patients expect to continue on a TNF inhibitor if it is effectively controlling their disease?
  
• Future biologic therapies are also discussed, which will offer arthritis patients even more treatment options in the coming years.
  

• Biologic agents offer patients hope of better outcomes than were seen previously with standard disease modifying drugs.
  
• Although a small percentage of patients will truly wind up without any significant pain after biologic therapies, a greater number will have some reduction in their joint pain and swelling associated with their rheumatic conditions.
  
• The book includes important background information about different types of arthritis, as well as traditional treatments (including NSAIDS, disease modifying drugs such as methotrexate, and corticosteroids).
  
• Newer drugs such as Celebrex, Mobic, Arava, and Kineret are also discussed.
  
• The book then focuses on the currently available TNF inhibitors Enbrel, Remicade, and Humira. Potential side effects are discussed in detail.
  
• Dr. Zashin describes each of the TNF inhibitors in separate chapters and helps to compare and contrast the three TNF inhibitors currently on the market.
  
• A self-testing questionnaire in the book helps indicate whether you would be a good candidate for TNF blocker therapy.
  
• More specific issues dealing with TNF inhibitors will be discussed in more depth in part II of Dr. Zashin's interview in our next podcast.
  
• If you enjoy our podcasts, don't forget to cast your vote at podcastalley.com so that other arthritis sufferers will be able to easier discover our podcasts as well.
  

• Can yoga truly help people reduce their weight? Or are yoga enthusiasts just more health conscious?
  
• It appears from a recent study that pain is having a significant impact on work productivity and absenteeism. If a person's pain is properly addressed and treated this can result in improved productivity and may make your supervisor happier as well.
  
• Sexually provocative and flirtatious behavior may not achieve the desired results at work. It appears that women who do sexually arousing things at work have fewer promotions and earn less money than women who avoid these activities.
  
• The controversy of whether non-steroidal anti-inflammatory drugs (NSAIDS) interfere with bone healing is discussed following the release of a new study out of Boston. Are the use of NSAIDS or narcotics just a reflection of the fact that the patient is in pain and that a bone fracture is not healing properly--rather than an actual cause of non-union of a fracture?
  
• Women appear to have lower exercise capacity than men and it is declining at the rate of 1% per year. Does a lower than expected ability to exercise for your age translate into an increased death rate? Dr. Rutstein addresses that issue as well as stressing the critical importance of including exercise as one of the "12 critical steps" to "take back control of your arthritis."
  

• Should rheumatoid arthritis patients be doing more rigorous resistance exercises to do more to increase muscle mass? A small study out of Wales suggests that this may be beneficial and cut down on disability. The importance of exercise as part of the treatment of rheumatoid arthritis and other rheumatic diseases is discussed.
  
• Hospitals can be "dangerous" places. This might be your conclusion after you hear some statistics about infections in Pennsylvania's hospitalized patients.
  
• Do optimists do better on average than pessimists when it comes to chronic illnesses? What is the relationship with the immune system? Find out why being optimistic about your condition may increase your chances of living longer with a better quality of life.
  
• A potential diagnosis of osteoporosis may literally leave you "dangling by your fingernails." A new tool to screen for osteoporosis based on fingernail clippings is in the testing phase.
  
• A Los Angeles Times reporter breaks a story about an investigation into 120 deaths in patients treated with a Duragesic (fentanyl) patch for pain.
  Possible other explanations for these fatalities is offered, along with warnings of how to use the patch correctly to avoid serious complications including death. Anyone currently using the patch or considering it should certainly be familiar with these critical points.
  
• I love milk chocolate--not dark chocolate, That's why I was ticked that Italian investigators found that dark chocolate (milk chocolate wasn't tested) helped reduce blood pressure in a small study of 20 patients. Learn why dark chocolate may be healthy for you.
  
• If you enjoy our Arthritis Central News and Views podcasts don't forget to cast your vote each month at Podcast Alley. This will increase our ranking among podcasts and enable others with arthritis and rheumatic disorders to find our program. Thanks for taking the time to do this.
  
  Download File - 5.7 MB
  Listen To This Podcast (Streaming Audio)
  
  

  ---

  
  ArthritisCentral News and Views #25 -- 08/31/05
  
  feedback@arthritiscentral.com (Joel Rutstein M.D.) Author: Joel Rutstein M.D.
  Wed, Aug 31, 2005
  
  
  
  
  • Have you ever experienced rudeness from a doctor? Then you will be interested in hearing about the inclusion of the teaching of communication skills and improved "bedside manner" to medical students. There may even be a relationship between how well you do medically and how your doctor interacts with you. In Take Back Control of Your Arthritis: The 12 Critical Steps, Step 1 is entitled "Find a Doctor You Can Trust." Your having the right doctor is the "foundation" of all of your subsequent treatment.
    
  • Statin drugs used to lower serum cholesterol levels may also offer patients an additional side benefit. Dr. Rutstein tells you about a recent study demonstrating fewer deaths from pneumonia in patients taking one of the statin medications.
    
  • Fibromyalgia patients may derive significant benefit from a drug used to treat Parkinson's disease. Mirapex (pramipexole) stimulates levels of dopamine in the brain. A study in fibromyalgia is discussed, which resulted in reduced levels of pain, improved functional activity, and clearer thinking. Although this is a small study, it is a promising one for those suffering with fibromyalgia.
    
  • Balacet 325 is a new pain medication that combines propoxyphene (Darvon) with a reduced amount of acetaminophen (Tylenol). Dr. Rutstein explains how this may allow those of you in pain to more safely take increased amounts of propoxyphene without an increased risk of liver damage.
    
  • A very important study comparing CellCept (mycophenolate mofetil) with Cytoxan (cyclophosphamide) and Imuran (azathioprine) for the treatment of systemic lupus erythematosus with kidney involvement is now underway. CellCept has been touted as a superior and safer way of treating lupus renal disease (lupus nephritis).
    
  • A study out of Sweden suggests that biologic therapy with TNF inhibitors like Enbrel or Remicade may actually have a "protective" cardio-vascular effect in rheumatoid arthritis patients. This runs counter to prior concerns about cardio-vascular risk secondary to these biologic agents.
    
  • The Medicare drug coverage plan is almost here and Dr. Rutstein brings you an update about this. For more information we suggest that you call 1-800-MEDICARE or visit their website at www.medicare.gov.
    
  • You can also call the Medicare Rx Education Network at 1-800-670-9006 or visit their website at MedicareRxEducation.org. We hope that you will be able to get the information that you need in order to figure out whether this will be beneficial for you.
    
  • If you enjoy our shows, don't forget to vote for our podcast. This will help other rheumatic disease patients find us and get all of this important information.
    
  
  
  Download File - 8.8 MB
  Listen To This Podcast (Streaming Audio)
  
  

  ---

  
  ArthritisCentral News and Views #24 -- 08/25/05
  
  feedback@arthritiscentral.com (Joel Rutstein M.D.) Author: Joel Rutstein M.D.
  Thu, Aug 25, 2005
  
  
  
  
  • Many patients with rheumatic diseases are overweight or even obese. This can create significant long-term problems with arthritis involving the weight-bearing joints in the lower extremities. Obesity increases the risk of diabetes, hypertension, and heart disease as well. It is, therefore, important to talk about weight reduction, diet, and exercise on our program.
    
  • Dr. Rutstein is devoting this program to a discussion of bogus weight loss products and false advertising claims made by these over-the-counter product companies.
    
  • Cortislim is the most recent product to gain notoriety. An article in the Los Angeles Times by Roy Rivenburg uncovers some of the scandalous information behind this product. You may be surprised to learn about "Dr" Greg Cynamoun's true past.
    
  • The Cortislim story illustrates some of the way other bogus products are "hawked" to the public.
    
  • People liked the empathetic message--'It's not your fault that you are overweight!" It's stress and increased cortisol that's the culprit.
    
  • Dr. Rutstein explains how the 1994 Dietary and Health Education Act has allowed unscrupulous companies to get away with these bogus claims and products.
    
  • Dr. Rutstein reiterates the importance of caloric intake and the number of calories you are burning through your daily activities and your exercise.
    
  • If you like our Podcasts, please remember to cast your vote each month at PodcastAlley.com. This will help bring our Podcast to the attention of other rheumatic disease patients. Thank you for your support!
    
  
  
  Download File - 6.2 MB
  Listen To This Podcast (Streaming Audio)
  
  

  ---

  
  ArthritisCentral News and Views #23 -- 08/17/05
  
  feedback@arthritiscentral.com (Joel Rutstein M.D.) Author: Joel Rutstein M.D.
  Wed, Aug 17, 2005
  
  
  
  
  • Lance Armstrong's seven Tour de France victories should not only be an inspiration to cancer patients, but also to chronic rheumatic disease sufferers. Read Lance's book "It's Not About the Bike: My Journey Back to Life" and use it to motivate you.
    
  • Dr. Rutstein's daughter Dr. Jessica has delivered his grandson, Colin Benjamin Hughes. Her determination to deliver the baby and avoid a C-section exemplifies the type of persistence you should demonstrate in battling your arthritis.
    
  • In newly developing countries, it appears that obesity is becoming an ever-increasing health problem. The people in these countries are subsequently at greater risk of diabetes mellitus, hypertension, and heart disease.
    
  • In fully developed countries, it appears that lower socio-economic groups are the ones more at risk of poor eating habits and weight problems.
    
  • Can losing weight cause you to make more money and be wealthier? You may be surprised to hear about the results of a recent study on this subject.
    
  • Poor children in early developing countries were the ones more at risk of future health problems based on a recent report in the British Medical Journal.
    
  • When you lose weight, how much decrease in the force applied on your knees is there? If you think that it's just pound for pound--you're wrong. Hear more about how the combination of weight loss and exercise can help you with your ability to function.
    
  • A simple device put over the outside of the soles of your shoes can help reduce the risk of falling out of doors due to ice, snow, wet surfaces, etc. This device is called the Yaktrax Walker (Yaktrax Inc., Port Orchard, Washington at www.yaktrax.com or 1-866-YAKTRAX).
    
  • Dr. Rutstein recounts his last few weeks dealing with fears about his daughter's pregnancy, his wife's malignancy, and his mother's back and leg pain. What looked somewhat bleak one month ago has now brightened considerably. This shows you why you need to keep your chin up and try to be optimistic in spite of what sometimes seems insurmountable odds.
    
  • If you enjoy the Podcast, please don't forget to cast your vote. Thanks for your support!